Benjamin Dewees, RAC, is Vice President of Regulatory Affairs and Quality at Kyverna Therapeutics. Mr. Dewees is a dedicated Regulatory professional with over 25 years of industry experience and over 20 of those years in Regulatory Affairs. He brings extensive experience in developing novel drug development pathways for patients with unmet medical needs. 

Mr. Dewees started his career starting up biologics manufacturing facilities; taking three GMP manufacturing facilities from design concept to fully operational clinical and commercial production. He then transitioned into Regulatory and has focused most of his career on orphan drug development with three separate product approvals in the US, Europe, and multiple other countries around the globe. Prior to starting at Kyverna, Mr. Dewees was the founder of Aperiam Consulting and held leadership positions at BioMarin Pharmaceuticals, Acer Therapeutics, Sangamo Therapeutics, and Tenaya Therapeutics. 

Mr. Dewees holds a bachelor’s degree from University of California, Santa Cruz and completed a two-year Biotechnology Certificate program at University of California, San Diego.